Davide Zamengo
Papers
2
Total Citations
36
H-Index
2
About
Davide Zamengo is a leading urological researcher whose work centers on optimizing prostate cancer diagnosis and treatment through minimally invasive techniques. His major contributions lie in refining biopsy protocols and establishing long-term outcomes for surgical approaches. In his landmark 2023 randomized controlled trial (25 citations), Zamengo challenged standard practice by comparing targeted prostate biopsy alone against the conventional combination of target plus systematic biopsy in men with positive multiparametric MRI. This pivotal study directly informs the ongoing debate on whether standard biopsy can be safely omitted in biopsy-naïve patients, potentially reducing overdiagnosis and procedural morbidity. Zamengo also co-authored a seminal 2024 study (11 citations) presenting the ten-year functional and oncological outcomes from a prospective randomized trial comparing laparoscopic versus robot-assisted radical prostatectomy. This work provides crucial long-term evidence on continence, potency, and cancer control, guiding surgeons and patients in choosing between these two minimally invasive approaches. Through these high-impact investigations, Zamengo has significantly advanced evidence-based urology, shaping contemporary protocols for prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2